An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
Non-vitamin K antagonist oral anticoagulants (NOACs) include thrombin inhibitor dabigatran and coagulation factor Xa inhibitors rivaroxaban, apixaban, edoxaban, and betrixaban. NOACs have several benefits over warfarin, including faster time to the achieve effect, rapid onset of action, fewer docume...
Main Authors: | Mark Terence P. Mujer, Manoj P. Rai, Varunsiri Atti, Ian Limuel Dimaandal, Abigail S. Chan, Shiva Shrotriya, Krishna Gundabolu, Prajwal Dhakal |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2020/7636104 |
Similar Items
-
Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
by: Osamu Kumano, et al.
Published: (2021-03-01) -
Do USMLE steps, and ITE score predict the American Board of Internal Medicine Certifying Exam results?
by: Supratik Rayamajhi, et al.
Published: (2020-03-01) -
Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
by: Frederique E. C. M. Peeters, et al.
Published: (2018-10-01) -
Anticoagulants in clinical practice. The place of vitamin K antagonists in combination with new oral anticoagulants
by: T. V. Vavilova
Published: (2015-12-01) -
Anticoagulation in sub-saharan africa with the advent of non-vitamin K antagonist oral anticoagulants
by: Raphael Chinedu Anakwue
Published: (2020-01-01)